Handbook of Biologics for Rheumatological Disorders

Handbook of Biologics for Rheumatological Disorders

Author: Neeraj Jain

Publisher: Springer Nature

Published: 2022-03-06

Total Pages: 286

ISBN-13: 9811672008

DOWNLOAD EBOOK

Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation of individual biologic agents and their best use in the new treatment regimens./div This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field./div This book is likely to benefit clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest. /div


Biologics for the Treatment of Rheumatoid Arthritis

Biologics for the Treatment of Rheumatoid Arthritis

Author: Ronald van Vollenhoven

Publisher: Springer

Published: 2015-12-22

Total Pages: 139

ISBN-13: 3319131087

DOWNLOAD EBOOK

This book provides a comprehensive overview of the available biologic therapies whilst comparing them to standard disease modifying anti-rheumatic drugs, and discusses how best to determine which therapy is most appropriate for an individual patient in the framework of current guidelines. Biologics for the Treatment of Rheumatoid Arthritis is an up-to-date and concise practical guide to the latest therapeutic developments in this field. This book is an invaluable source of topical information for all rheumatologists and health care professionals treating patients with rheumatoid arthritis.


Biologics in Rheumatology

Biologics in Rheumatology

Author: Coziana Ciurtin

Publisher:

Published: 2016

Total Pages: 539

ISBN-13: 9781634853026

DOWNLOAD EBOOK

Significant progress has been acquired in the treatment of rheumatic conditions with the introduction of biologic therapies, which has enabled better control of disease activity and improved patients' long-term outcome. Apart from several biologic treatments already licensed for use in autoimmune rheumatic conditions, numerous other agents are currently under investigation. This rapid expansion of the therapeutic armamentarium requires a critical analysis of individual biologic options and their clinical indications, in order to facilitate the optimal use of these new therapies. The authors felt that a comprehensive book revisiting all the evidence available regarding the efficacy, cost-effectiveness and health implications of the use of biologics in rheumatology was needed in order to integrate the clinical, ethical and socio-economic aspects related to their use. This book is aimed at specialist doctors, trainees, nurses and health professionals working in the field of rheumatology. It critically appraises the level of evidence behind the use of biologic agents in diverse autoimmune diseases, comprising separate chapters which focus on rheumatoid arthritis, systemic lupus erythematosus, myositis, systemic sclerosis, Sjogren's syndrome, seronegative spondyloarthropathies, psoriatic arthritis and psoriasis, small, medium and large vessel vasculitis, osteoporosis, and interstitial lung disease associated with rheumatic conditions. In addition, the book explores aspects related to the use of biologic agents, such as ethical considerations of consenting patients to take part in clinical trials with biologics, and adolescent and adult rheumatology nurse perspectives related to patients' benefits of biologic therapies. Particular interest is given to the use of biologics during pregnancy and assessment of their infectious risks. A separate chapter explores the off-target benefits associated with the use of anti-TNF therapies. Several chapters include data about cost-effectiveness, and national and international guidelines for the use of biologic agents in different rheumatic conditions.


Biologics in General Medicine

Biologics in General Medicine

Author: W.-H. Boehncke

Publisher: Springer Science & Business Media

Published: 2007-05-08

Total Pages: 202

ISBN-13: 3540290176

DOWNLOAD EBOOK

This is the first book to cover every angle in the clinical application of biologics. Readers will not only find that all of the biologics currently approved for clinical use are delineated in a standardized way, but also the "differential therapy" with biologics in fields including dermatology and neurology is described in detail and summarized in treatment algorithms. Shorter sections on biologic biotechnology as well as safety and regulatory issues complement the more clinically-oriented central chapters.


Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

Author: John J Cush

Publisher: Elsevier Health Sciences

Published: 2012-11-28

Total Pages: 183

ISBN-13: 145575059X

DOWNLOAD EBOOK

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.


Early Rheumatoid Arthritis

Early Rheumatoid Arthritis

Author: Paul Emery

Publisher:

Published: 2005

Total Pages: 0

ISBN-13: 9781416027676

DOWNLOAD EBOOK

This issue covers the latest developments in the understanding of rheumatoid arthritis at the early stage. Treatments such as with newer biologic agents and conventional disease-modifying antirheumatic drugs are reviewed. Also included are articles on imaging modalities as a means of identifying those in the early stages and monitoring response to treatment.


Biologics, Biosimilars, and Biobetters

Biologics, Biosimilars, and Biobetters

Author: Iqbal Ramzan

Publisher: John Wiley & Sons

Published: 2021-02-03

Total Pages: 328

ISBN-13: 1119564654

DOWNLOAD EBOOK

A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists


Infection and Malignancy in Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America, E-Book

Infection and Malignancy in Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America, E-Book

Author: Kevin Winthrop

Publisher: Elsevier Health Sciences

Published: 2016-11-29

Total Pages: 177

ISBN-13: 0323496768

DOWNLOAD EBOOK

This issue of Rheumatic Disease Clinics will include articles such as: Vaccines and Biologics- efficacy and toxicity; Improving Vaccine administration in Practice; HCV and rheumatology; HBV reactivation and rheumatic disease; Herpes zoster in rheumatic diseases; Opportunistic infections in biologic therapy, risk and prevention; and many more!


The Handbook of Biological Therapy

The Handbook of Biological Therapy

Author: Bruce Kirkham

Publisher: OUP Oxford

Published: 2008-11-27

Total Pages: 176

ISBN-13: 0191548979

DOWNLOAD EBOOK

Drugs produced by molecular biological techniques, called the 'biologics', differ from the usual chemical medications. Their optimum use, and the detection and managemenet of adverse events, pose a significant challenge to the clinician. Licences for new biologics continue to be granted for the likes of rituximab, abatacept and certocizumals pegol. Intensive research is also defining new areas in which these drugs will be used in the future, increasing the number of practitioners using biologics. As the use of these drugs increases around the world, so the level of information needed by primary care practitioners and specialist prescribers needs to be expanded The Handbook of Biological Therapy provides the practising clinician with a practica guide to the use of Tumour Necrosis Factor Blocking Therapy (TNF-blockers), and important new class of biologic therapy for rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, and psoriatic arthritis. It is a comprehensive distillation of the authors' clinical experience with these drugs, combined with data from diverse databases offering practical advice on their uses, specific indications, supporting clinical trial data and safety issues, with the aim of making the use of these drugs easier for the busy clinician. All of the authors have been involved from the beginnings of the clinical trial programmes with these drugs and continue to use them in daily practice.